Related Experiment Video
Updated: Aug 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Enhanced thrombin generation in children with sickle cell disease
M Peters1, B E Plaat, H ten Cate
1Emma Kinderziekenhuis/Children's Academic Medical Center, Amsterdam, The Netherlands.
Insights
Children with sickle cell disease (SCD) show increased thrombin generation, a marker of blood clot formation. This may be linked to lower levels of protein C and protein S, crucial coagulation inhibitors in pediatric SCD patients.
Area of Science:
- Hematology
- Pediatric Medicine
- Thrombosis Research
Background:
- Sickle cell disease (SCD) is an inherited blood disorder with significant childhood morbidity.
- Vascular occlusion in SCD may involve increased coagulation system activity.
- Previous studies on coagulation in SCD primarily focused on adult populations.
Purpose of the Study:
- To investigate coagulation system activity in children with sickle cell disease.
- To assess markers of thrombin generation and coagulation inhibitors in pediatric SCD patients.
Main Methods:
- Prospective study comparing 16 homozygous SCD patients with 16 age-matched controls.
- Measurement of prothrombin fragment F1+2 and thrombin-antithrombin III (TAT) complexes.
- Assessment of protein C activity, total and free protein S, and antithrombin III (AT III) levels.
Main Results:
- SCD patients exhibited significantly elevated plasma concentrations of F1+2 and TAT complexes.
- Significantly reduced levels of protein C activity and total/free protein S were observed in SCD patients.
- Plasma AT III levels did not differ between SCD patients and controls.
Conclusions:
- Children with SCD demonstrate evidence of enhanced thrombin generation.
- Reduced levels of protein C and protein S may contribute to the observed hypercoagulable state in pediatric SCD.
- Further research is needed to establish the clinical significance of this coagulation imbalance in childhood SCD.
Abstract:
Recent studies suggest that increased activity of the coagulation system, measured with sensitive assays for activation markers, may be important in the pathogenesis of vascular occlusion in sickle cell disease (SCD). Since most of these studies were carried out in adult patients and SCD is an inherited disorder with severe morbidity even in childhood, we decided to determine the activity of the coagulation system in children with SCD. In a prospective study markers of thrombin generation as well as coagulation inhibitors were investigated in 16 homozygous SCD patients and 16 age-matched control children. Significantly increased plasma concentrations of the prothrombin fragment F1+2 and of thrombin-antithrombin III (TAT) complexes were found in SCD patients. The levels of protein C activity and total and free protein S were significantly reduced in SCD patients as compared with control values. Plasma AT III levels were not different in the two groups. We conclude that, in children with SCD, evidence of enhanced thrombin generation is present, which may in part be due to reduced levels of the inhibitors proteins C and S. The clinical relevance of this coagulation imbalance has to be demonstrated.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care

